ARCHIVES

House Committee Adds $73 Million To President’s NCI Budget, Only $13 Million Under Senate Figure

This article is from The Cancer Letter archive.

Vol. 10 No. 31 | August 3, 1984

Download PDF Visit The Full Archive

Related Articles

In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List

December 2, 1983

Genetic Risk Factor Implicated In Prostate Cancer In Blacks

August 25, 2006

In Brief: President OK’s Mammography Standard Publication, CDC State Grants Increase

January 7, 1994

Five Awards Expected In Annual CCP Review; 21 Applicants Compete For Limited Funding

February 1, 1991

Collaborative Drug Development Groups Clear BSC Overview, Natural Products RFA To Proceed

June 10, 1988

In Brief: Mansfield To Head NCI Radiation Research; Cowan Is Acting Chief, Medicine Branch

June 23, 1995